{"DataElement":{"publicId":"2195171","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Connective Tissue Fibrosis Grade","preferredDefinition":"in CTC category Musculoskeletal/Soft Tissue, assessment of the severity of a deep connective tissue fibrosis adverse event using a graded scale.","longName":"CTC_AE_CONTIS_FIB_GD","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195169","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Connective Tissue Fibrosis","preferredDefinition":"information related to the CTC adverse event of deep connective tissue fibrosis.","longName":"CTC_AE_CONTIS_FIB","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2480706","version":"1","preferredName":"Common Terminology Criteria for Adverse Events","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","longName":"C49704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A63CA-49B0-49FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-07","modifiedBy":"ONEDATA","dateModified":"2006-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2660696","version":"1","preferredName":"Connective Tissue Fibrosis","preferredDefinition":"Supporting tissue that surrounds other tissues and organs. Specialized connective tissue includes bone, cartilage, blood, and fat.:The growth of fibrous tissue.","longName":"C12374:C3044","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Connective Tissue","conceptCode":"C12374","definition":"The supporting or framework tissue of the animal body, formed of fibrous and ground substance with more or less numerous cells of various kinds; it is derived from the mesenchyme, and this in turn from the mesoderm; the varieties of connective tissue are: areolar or loose; adipose; dense, regular or irregular, white fibrous; elastic; mucous; and lymphoid tissue; cartilage; and bone; the blood and lymph may be regarded as connective tissues the ground substance of which is a liquid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fibrosis","conceptCode":"C3044","definition":"The formation of fibrous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E73C82-C9B4-5882-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBC19B2D-DC88-603E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2195170","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Connective Tissue Fibrosis Grade","preferredDefinition":"in CTC category Musculoskeletal/Soft Tissue, assessment of the severity of a deep connective tissue fibrosis adverse event using a graded scale.","longName":"CTC_AE_CONTIS_FIB_GD","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED167324-2879-2FD4-E034-0003BA3F9857","beginDate":"2004-08-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"1","valueDescription":"Increased density, \"spongy\" feel","ValueMeaning":{"publicId":"2572723","version":"1","preferredName":"Increased density, \"spongy\" feel","longName":"2572723","preferredDefinition":"Increased density, \"spongy\" feel","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E920-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SHIDED","dateModified":"2005-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED167324-287C-2FD4-E034-0003BA3F9857","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"2","valueDescription":"Increased density with firmness or tethering","ValueMeaning":{"publicId":"2572724","version":"1","preferredName":"Increased density with firmness or tethering","longName":"2572724","preferredDefinition":"Increased density with firmness or tethering","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E921-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SHIDED","dateModified":"2005-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED167324-2880-2FD4-E034-0003BA3F9857","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"3","valueDescription":"Increased density with fixation of tissue; operative intervention indicated; interfering with ADL","ValueMeaning":{"publicId":"2572725","version":"1","preferredName":"Increased density with fixation of tissue; operative intervention indicated; interfering with ADL","longName":"2572725","preferredDefinition":"Increased density with fixation of tissue; operative intervention indicated; interfering with ADL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E922-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SHIDED","dateModified":"2005-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED167324-2884-2FD4-E034-0003BA3F9857","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"4","valueDescription":"Life-threatening; disabling; loss of limb; interfering with vital organ function","ValueMeaning":{"publicId":"2572726","version":"1","preferredName":"Life-threatening; disabling; loss of limb; interfering with vital organ function","longName":"2572726","preferredDefinition":"Life-threatening; disabling; loss of limb; interfering with vital organ function","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E923-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SHIDED","dateModified":"2005-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED167324-2888-2FD4-E034-0003BA3F9857","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"5","valueDescription":"Death","ValueMeaning":{"publicId":"2567604","version":"1","preferredName":"Death","longName":"2567604","preferredDefinition":"The cessation of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D521-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"COOPERM","dateModified":"2015-11-24","changeDescription":"Added the NCIt concept definition as the System Generated definition per request by NMDP. mc 11/24/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED167324-288B-2FD4-E034-0003BA3F9857","beginDate":"2002-10-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184299","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"Grade","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1C87-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED16587F-CBB5-2FCA-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812032","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000132","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CTC Adverse Event Fibrosis-de","type":"Preferred Question Text","description":"CTC Adverse Event Fibrosis-deep connective tissue Grade","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Fibrosis-deep connective tissue Grade","url":null,"context":"CTEP"},{"name":"Source","type":"DATA_ELEMENT_SOURCE","description":"Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)","url":"http://ctep.cancer.gov/reporting/ctc.html","context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ED1659E0-BF58-2FD0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"REEVESD","dateModified":"2011-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}